This author has not written his bio yet.
But we are proud to say that Marketwired contributed 101 entries already.
LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA–(Marketwired – Aug 6, 2015) – GSK (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) announce the approval in Canada of BREO® ELLIPTA® (fluticasone furoate/vilanterol […]
LOUISVILLE, CO–(Marketwired – August 04, 2015) – GlobeImmune, Inc. (NASDAQ: GBIM) announced today that Celgene Corporation exercised its option under the 2009 Collaboration and Option Agreement to exclusively license GI-6207, […]
PHOENIX, AZ–(Marketwired – Aug 4, 2015) – Insys Therapeutics, Inc. (NASDAQ: INSY) (“Insys” or “the Company”) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug […]
LAVAL, QUEBEC–(Marketwired – Aug. 4, 2015) – ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF), (“ProMetic” or the “Corporation”) announced today that an orphan drug designation status has been granted for its human […]
NEW YORK, NY–(Marketwired – July 30, 2015) – PharmaCyte Biotech (OTCQB: PMCB) is a small international biotechnology firm, but you wouldn’t know it by the company it keeps. How does […]
SHYFT Analytics Delivers Transformational Insights to Life Sciences With Next Generation Real World Evidence Analytics Platform WALTHAM, MA–(Marketwired – Jul 29, 2015) – SHYFT Analytics, a leader in cloud-based data […]
DUBLIN, IRELAND–(Marketwired – Jul 27, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated products that address […]
Latest Approval Expands Product Label in Canada and Further Strengthens Global Brand for Once-Daily, Dual Mechanism Antibiotic DUBLIN, IRELAND–(Marketwired – Jul 23, 2015) – Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance […]
DUBLIN, IRELAND–(Marketwired – Jul 21, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines […]
DUBLIN, IRELAND–(Marketwired – Jul 20, 2015) – Second-quarter 2015 net sales expected to be in the range of $170 to $172 million Full-year 2015 net sales guidance range increased to […]
